Biotech firms target weight-loss drugs without Wegovy’s side-effects
Switzerland-based Aphaia Pharma, in May launched its Phase II clinical trial of its daily glucose formulation, which is taken mixed with water. It curbs appetite by restoring the natural release of GLP-1 and other hormones, without causing nausea, Phase I data showed.
Biotech firms target weight-loss drugs without Wegovy’s side-effects Read More »